scholarly journals COVID-19 in occupational settings: lessons from 100 years ago and addressing the disease today

2020 ◽  
Vol 32 (2 (Supp)) ◽  
pp. 255-260
Author(s):  
Bobby Joseph ◽  
Mia George Kallumkal

COVID-19 is a disease caused by the novel coronavirus (SARS-CoV-2). On January 30th, 2020 the outbreak of Novel Coronavirus 2019 was declared a Public Health Emergency of International Concern by the World Health Organization. COVID-19 was declared a pandemic on the 11th of March 2020. The virus spreads from person to person through close contact, touching contaminated surfaces and then touching the eyes, nose or mouth. Preventive measures are taken at all workplaces to stop the spread of COVID-19. Social distancing, regular hand washing with soap and water for 20 seconds, use of alcohol- based hand sanitizer and cough etiquette must be practiced at all times. Hospitals, schools, colleges, hospitality, apparel and manufacturing industries now practice hand hygiene, social distancing, regular disinfection of contaminated surfaces, staggered work shifts, correct use of face mask if mild symptoms develop and shutting down of establishments as per instructions of the local health authorities. COVID-19 is already affecting tens of millions of informal workers all around the world. India has a share of almost 90 percent of working people which amount to 400 million workers in the informal economy, who are at the risk of falling into poverty during this crisis. The current lock down measures in India have affected these workers, compelling them to return to rural areas. Poverty along with the spread of the COVID-19 would further worsen the situation. Without dwelling on the healthcare setting, this paper discusses various preventive measures to be implemented in three different sectors. These interventions can be adapted to others as well, to stop the transmission of COVID-19.

2020 ◽  
Vol 3 (2) ◽  
pp. 130
Author(s):  
Kelly Kelly ◽  
Lie Rebecca Yen Hwei ◽  
Gilbert Sterling Octavius

Since the beginning of 2020, the world has been affected by the novel coronavirus COVID-19 pandemic. The virus’ infectious nature pushed all sectors to implement social distancing measures in an effort to limit its transmission, including the education sector. We searched PubMed and Science Direct on June 12th and found 24 papers that are relevant to our review. After the World Health Organization announced that COVID-19 is a global threat, various countries took a variety of measures to limit the disease spread such as social distancing, self-quarantine, and closing public facilities that hold large gatherings, including universities and schools. Hospitals started to prioritize services for COVID-19 cases. Medical education programs are also affected by this disease, but not continuing in-person classes outweighs any benefit from traditional teaching methods. The previous Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) pandemics have shown ways to shift medical education to online platforms. In the current pandemic, online meetings are being used to hold lectures, classes, laboratory practices, and clinical skills classes. For clerkship students, online platforms might not be feasible because this eliminates patient-doctor relationships, but it appears for now to be the only option. Some institutions have involved medical students in the frontlines altogether. We encourage all parties to constantly evaluate, review, and improve the efforts of continuing medical education, especially during this pandemic. Further research is needed to evaluate students’ performance after adopting e-learning and to discover the best methods in medical education in general and clerkship education in particular.


2020 ◽  
Author(s):  
Manoj Kumar Yadav ◽  
Arpana Vibhuti ◽  
Anjali Priyadarshini ◽  
Archana Gupta ◽  
V. Samuel Raj ◽  
...  

World Health Organization (WHO) announced the official name of the 2019 novel coronavirus associated diseases coronavirus disease (COVID-19) and the reference name for the virus is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).Transmission of SARS CoV-2 in humans occurs mainly via respiratory droplet or aerosols, close contact with an infected person, exposed to coughing, sneezing and likely in oral-faecal. The COVID-19 outbreak started in different countries at different times, and now those countries are at different stages. By comparing infection trajectories from the 100th case mark, we have been able to observe the rapid spread of the virus in various countries. To date, no specific antiviral drugs or vaccines are available for the control of SARS CoV-2. The experts at global level suggest implementation of strict measures such as practicing quarantine, social distancing, avoiding social gathering to reduce the number of COVID-19 cases. This is a dynamically unfolding pandemic that will require the concerted efforts of counties around the world to control. Given the unfold of the new coronavirus and its impacts on human health, it becomes pertinent to device methods for handling this public health emergency at the community, national, and international levels. it's vital to additional investigate a preventative intervention to halt the unfold of the COVID-19 infection, because it has been discovered that not all countries have constant fate concerning infection and fatality. It becomes vital to acknowledge and study the factors accountable and also the underlying mechanisms for this.


Author(s):  
Abdul Ghafar Sherzad ◽  
Yan Tu ◽  
Weitao Liu ◽  
M. Azim Azimee ◽  
Nemat Arash ◽  
...  

The novel coronavirus, or COVID-19, emerged from Wuhan, Hubei Province, China, and has recently spread all over the world. During the COVID-19 pandemic, healthcare workers struggle against this microscopic enemy due to their job responsibilities, thus leading to be infected in some of them, even some of them are died in line of duty. As of 2 February 2021, 37 million cases of COVID-19 among health workers from 183 countries and regions were reported to the World Health Organization (WHO), a figure that represents 36% of the total cases globally. The median age of these cases was 42 years and 68% were women. On May 24, 2021, the World Health Organization (WHO) stated that at least 115,000 healthcare workers have died due to COVID-19 worldwide since the pandemic began last year.  It is important to pay attention to the situation related to COVID-19 infection for medical staff and their preventive measures. This paper reviews the literature on all available information about the situation and preventive measures (The primary prevention of COVID-19 is to break the chain of transmission from infected to healthy people, secondary preventive measures comprise the use of health screening and recognition activities to ascertain those infected with COVID-19 and tertiary prevention consists of treatment and proper rehabilitation) related to COVID-19 infection for medical staff.


2020 ◽  
Author(s):  
Aneesh Kumar K V

BACKGROUND The World Health Organization (WHO) declared 2019-20 coronavirus outbreak as a Public Health Emergency of International Concern (PHEIC) on 30 January 2020 and pandemic on 11 March 2020. As of today, 17 May 2020 around 3,16,520 death and 47,99,266 coronavirus infected cases are reported worldwide. There is about 26,25,463 active cases are now under treatment and several lakhs of people are under quarantine. Therefore, an attempt has been made to explain briefly about the characteristics of the virus, current review, COVID-19 symptoms, precautions, available vaccines etc. In addition, a case study was also conducted to provide the dangerous picture of drastic growth of infected people around the world during the span of time. OBJECTIVE World Health Organization (WHO) has announced the COVID-19 outbreak as a global public health emergency and pandemic, spreading fast with an increasing number of infected patients worldwide. At present, no vaccines are available for the treatment of patients with COVID_19 disease. A case study was conducted to provide the dangerous picture of exponential growth of infected people around the world to inculcate the awareness of maintaining social distancing and hand hygiene. This effort is made in view of providing awareness to the public effectively to understand and deal with the novel coronavirus situation worldwide. It is also anticipated to provide a reference to future advances in medical anti-virus related studies. METHODS A case study was conducted to provide the dangerous picture of exponential growth of infected people around the globe. For our study, we preferred five most coronavirus effected countries in the world viz., China, Itali, USA, Spain, India in the month of February and March 2020, and later extended to 17 May 2020. Based on the current published evidence, we precisely summarize the disease, characteristics of the virus, current world scenario, available treatment options and preventive measures to be taken against COVID-19. RESULTS Effort is made in view of providing awareness to the public effectively to understand and deal with the novel coronavirus situation worldwide.The medicines like Remdesivir, Chloroquine and Hydroxychloroquine, Ritonavir/Lopinavir and combined with Interferon beta are the experimental treatments currently being researched. Treatment with Lopinavir and Ritonavir or Chloroquine should be recommended in older patients with serious symptoms. The main risk factor of COVID-19 is travel and exposure to the virus. Lockdown, quarantine and thereby maintaining the ‘social distancing’ are the suitable method for controlling the out spread of coronavirus. Moreover, it is individual’s responsibility to take prompt measures to control the fast spreading of this virus disease. CONCLUSIONS The COVID-19 disease is spreading fast uncontrolled with an increasing number of infected patients worldwide. Our case study details the dangerous picture of exponential growth of infected people around the globe. The exact source, characteristics of the virus is unknown and no suitable drugs have been developed as of today. Symptomatic treatments are available and the list is provided, no need to panic. Conclusion is to inculcate the awareness of maintaining social distancing and hand hygiene. Anticipated to provide a reference to future advances in medical antivirus related studies.


2020 ◽  
Author(s):  
Micael Davi Lima de Oliveira ◽  
Kelson Mota Teixeira de Oliveira

According to the World Health Organisation, until 16 June, 2020, the number of confirmed and notified cases of COVID-19 has already exceeded 7.9 million with approximately 434 thousand deaths worldwide. This research aimed to find repurposing antagonists, that may inhibit the activity of the main protease (Mpro) of the SARS-CoV-2 virus, as well as partially modulate the ACE2 receptors largely found in lung cells, and reduce viral replication by inhibiting Nsp12 RNA polymerase. Docking molecular simulations were performed among a total of 60 structures, most of all, published in the literature against the novel coronavirus. The theoretical results indicated that, in comparative terms, paritaprevir, ivermectin, ledipasvir, and simeprevir, are among the most theoretical promising drugs in remission of symptoms from the disease. Furthermore, also corroborate indinavir to the high modulation in viral receptors. The second group of promising drugs includes remdesivir and azithromycin. The repurposing drugs HCQ and chloroquine were not effective in comparative terms to other drugs, as monotherapies, against SARS-CoV-2 infection.


Author(s):  
Ghotekar D S ◽  
Vishal N Kushare ◽  
Sagar V Ghotekar

Coronaviruses are a family of viruses that cause illness such as respiratory diseases or gastrointestinal diseases. Respiratory diseases can range from the common cold to more severe diseases. A novel coronavirus outbreak was first documented in Wuhan, Hubei Province, China in December 2019. The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID-19) a pandemic. A global coordinated effort is needed to stop the further spread of the virus. A novel coronavirus (nCoV) is a new strain that has not been identified in humans previously. Once scientists determine exactly what coronavirus it is, they give it a name (as in the case of COVID-19, the virus causing it is SARS-CoV-2).


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 862-869
Author(s):  
Meena Kumari ◽  
Monika Agrawal ◽  
Rakesh Kumar Singh ◽  
Parameswarappa S Byadgi

Currently, the world is facing a health and socioeconomic crisis caused by the novel coronavirus disease COVID-19. On 11 March 2020, the World Health Organization (WHO) has declared this disease as a pandemic. The condition (COVID-19) is an infectious disorder triggered by a newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2. Most of the COVID-19 infected patients will experience mild to moderate respiratory symptoms and recover without any unique therapy. Assessment of the clinical and epidemiological characteristics of SARS-CoV-2 cases suggests the infected patients will not be contagious until the onset of severe symptoms and affects the other organs. Well-differentiated cells of apical airway epithelia communicating with ACE2 were promptly infected to SARS-CoV-2 virus. But the expression of ACE 2 in poorly differentiated epithelia facilitated SARS spike (S) protein-pseudo typed virus entry and it is replicated in polarized epithelia and especially exited via the apical surface. Limiting the transmission of COVID-19 infection & its prevention can be regarded as a hierarchy of controls. In this article, we briefly discuss the most recent advances in respect to aetiology, pathogenesis and clinical progression of the disease COVID-19.


The COVID-19 pandemic identified in Wuhan, China in December 2019, has spread almost to all the countries of the world. The mitigation measures imposed by most of the nations to prevent the spread of COVID-19 have badly hit the global economic activities. As per the latest estimates, the world economy is predicted to decline by 5.2 percent, and world trade is expected to drop by 13-32 percent in 2020 due to the COVID-19 pandemic. In this way it has created havoc in the world economy and the Indian economy is no exception. The International Monetary Fund (IMF) has estimated the Indian GDP growth at 1.9 percent and showed the worst growth performance of India after the liberalisation policy of 1991. According to the World Bank, the Indian economy will contract by 3.2 percent in 2020-21. Daily wage labourers and other informal workers, particularly migrant labourers of economically poor states were the worst hit during the lockdown period and will continue to be adversely affected even after the lockdown was relaxed. The paper suggested multiple measures to support the Indian economic and financial support to all the families of the informal economy workers to tide over this crisis.


Author(s):  
Lara Bittmann

On December 31, 2019, WHO was informed of cases of pneumonia of unknown cause in Wuhan City, China. A novel coronavirus was identified as the cause by Chinese authorities on January 7, 2020 and was provisionally named "2019-nCoV". This new Coronavirus causes a clinical picture which has received now the name COVID-19. The virus has spread subsequently worldwide and was explained on the 11th of March, 2020 by the World Health Organization to the pandemic.


Coronaviruses ◽  
2020 ◽  
Vol 1 (1) ◽  
pp. 49-56
Author(s):  
Gaurav M. Doshi ◽  
Hemen S. Ved ◽  
Ami P. Thakkar

The World Health Organization (WHO) has recently announced the spread of novel coronavirus (nCoV) globally and has declared it a pandemic. The probable source of transmission of the virus, which is from animal to human and human to human contact, has been established. As per the statistics reported by the WHO on 11th April 2020, data has shown that more than sixteen lakh confirmed cases have been identified globally. The reported cases related to nCoV in India have been rising substantially. The review article discusses the characteristics of nCoV in detail with the probability of potentially effective old drugs that may inhibit the virus. The research may further emphasize and draw the attention of the world towards the development of an effective vaccine as well as alternative therapies. Moreover, the article will help to bridge the gap between the new researchers since it’s the current thrust area of research.


Sign in / Sign up

Export Citation Format

Share Document